Nanomi

Nanomi is leader in the field of microsphere and nanoparticle development of long-acting release injectables. The company is located in the green surroundings of Oldenzaal and is a subsidiary of Lupin ltd. The Nanomi team is young and internationally oriented. The working atmosphere is informal and dynamic, with personal development and humor as important pillars. Nanomi has developed a cutting-edge technology - the Microsieve technology - for the development of long-acting release medicines, a technology that offers unprecedented drug development potential for the future. The Microsieve technology is unique in that it guarantees production of medicines with uniform particle size,...

Drug delivery,controlled release,parenterals,encapsulation of small molecules,proteins and peptides,membrane emulsification,generics and supergenerics,microspheres,specialty niche products,and nanospheres

Nanomi operates in the Pharmaceutical manufacturing industry.

Nanomi's revenue is 11m - 100m

Nanomi has 11 - 50 employees.